middle.news
OncoSil Medical Expands Global Reach and Boosts Cash Reserves in Q2 FY25
8:48am on Thursday 30th of January, 2025 AEDT
•
Medical
Read Story
OncoSil Medical Expands Global Reach and Boosts Cash Reserves in Q2 FY25
8:48am on Thursday 30th of January, 2025 AEDT
Key Points
New exclusive distribution agreements signed for GCC, Egypt, and Nordic regions
UKCA and MDR certifications renewed, easing market access in Europe and UK
G-BA approval for German clinical trial under Coverage with Evidence Development program
First OncoSil treatments initiated in Italy and Australia’s TRIPP-FFX trial enrolment progresses
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Oncosil Medical (ASX:OSL)
OPEN ARTICLE